John L Carroll Selected Research

Collagen Type I (Type I Collagen)

1/2020

Respiratory defects in the CrtapKO mouse model of osteogenesis imperfecta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John L Carroll Research Topics

Disease

21	Hypoxia (Hypoxemia) 01/2020 - 01/2003
8	Hyperoxia 01/2019 - 01/2003
2	Bronchopulmonary Dysplasia 01/2020 - 10/2010
1	Emphysema 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2020
1	Hypercapnia 01/2019
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2013
1	Pneumonia (Pneumonitis) 02/2011
1	Pulmonary Hypertension 10/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2010
1	Apnea 04/2004
1	Obesity 04/2004
1	Obstructive Sleep Apnea 06/2003
1	Ganglion Cysts (Ganglion) 01/2003

Drug/Important Bio-Agent (IBA)

9	CalciumIBA 01/2015 - 09/2009
8	Oxygen (Dioxygen)IBA 08/2015 - 04/2004
4	CatecholaminesIBA 01/2014 - 09/2009
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012 - 11/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2010
2	Adenosine Triphosphate (ATP)IBA 01/2014 - 01/2012
2	Messenger RNA (mRNA)IBA 06/2011 - 01/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2011 - 10/2010
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	propargylglycineIBA 08/2015
1	Alanine (L-Alanine)FDA Link 08/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2015
1	Aminooxyacetic AcidIBA 08/2015
1	sodium bisulfide (NaHS)IBA 08/2015
1	LyasesIBA 08/2015
1	CystathionineIBA 08/2015
1	Cysteine (L-Cysteine)FDA Link 08/2015
1	NAD (NADH)IBA 01/2015
1	Dithionite (Sodium Dithionite)IBA 01/2015
1	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA 01/2015
1	AMP-Activated Protein KinasesIBA 05/2014
1	AICA ribonucleotide (ZMP)IBA 05/2014
1	4- hydroxy- 3- (4- (2- hydroxyphenyl)phenyl)- 6- oxo- 7H- thieno(2,3- b)pyridine- 5- carbonitrileIBA 05/2014
1	Cyanides (Isocyanides)IBA 01/2014
1	Sodium CyanideIBA 01/2014
1	AutoreceptorsIBA 01/2012
1	tributyl phosphate (TBP)IBA 10/2011
1	IsomerasesIBA 10/2011
1	RNA Polymerase II (RNA Polymerase B)IBA 10/2011
1	18S Ribosomal RNAIBA 10/2011
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 10/2011
1	Diazoxide (Hyperstat)FDA Link 08/2011
1	Glyburide (Glibenclamide)FDA LinkGeneric 08/2011
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 06/2011
1	Charybdotoxin (ChTX)IBA 06/2011
1	Nicotine FDA Link 01/2009
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 11/2005
1	Ether (Diethyl Ether)IBA 04/2005
1	E 4031IBA 04/2005
1	Fura-2 (Fura 2)IBA 04/2005
1	antiarrhythmic peptide (AAP)IBA 06/2003
1	Dopamine (Intropin)FDA LinkGeneric 01/2003
1	Pharmaceutical PreparationsIBA 01/2003

Therapy/Procedure

1	Cannula 01/2020
1	Ambulatory Care (Outpatient Care) 12/2013